IBN (InvestorBrandNetwork) Announces ‘Get Authentic’ Interview with NFL Hall of Famer Brett Favre and Odyssey Health Inc.’s Dr. Jacob VanLandingham
09 août 2022 08h00 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN, a multifaceted financial news and publishing company for private and public entities, today announces that NFL Hall of Famer...
electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference
05 août 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan...
electroCore Announces Record Second Quarter 2022 Financial Results
04 août 2022 16h05 HE
|
electroCore, Inc.
Record second quarter 2022 net sales of $2.2 million, increased 70% over second quarter 2021 and 14% sequentially Company to host a conference call and webcast today, August 4, 2022 at 4:30 pm EDT ...
Odyssey Health, Inc. Launches New Corporate Website
04 août 2022 08h00 HE
|
Odyssey Health, Inc
Las Vegas, NV, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products, is...
electroCore to Announce Second Quarter 2022 Financial Results on August 4
28 juil. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the...
Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug
12 juil. 2022 08h00 HE
|
Odyssey Health, Inc
Las Vegas, NV, July 12, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
electroCore, Inc. Announces Study of gammaCore Sapphire™ for the Treatment of Post-COVID Syndrome
07 juil. 2022 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced Mayo Clinic is initiating an...
Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug
29 juin 2022 08h30 HE
|
Odyssey Health, Inc
Las Vegas, NV, June 29, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...
RedChip Interviews Odyssey Health, Inc.’s CEO Michael Redmond
08 juin 2022 16h30 HE
|
Odyssey Health, Inc
Las Vegas, NV, June 08, 2022 (GLOBE NEWSWIRE) -- RedChip Companies will air a new C-Level interview with Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc. on The RedChip...
Odyssey Health, Inc. Completes Safety Evaluation of Cohort I for Concussion Drug
01 juin 2022 09h00 HE
|
Odyssey Health, Inc
Irvine, CA, June 01, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products,...